Remicade (infliximab) 100 mg, 20 mL, 1 vial, MSD Remicade (infliximab) is used for approved inflammatory conditions including rheumatoid arthritis. International medicine delivery with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications of the active substances of the drug Infliximab
Rheumatoid arthritis in active form in patients 18 years of age and older (in combination with methotrexate) with ineffectiveness of previous therapy, including treatment with methotrexate.
Crohn's disease in active severe form (including with the formation of fistulas) in patients 18 years of age and older, not amenable to standard therapy, including corticosteroids and/or immunosuppressants.
Crohn's disease in active, moderate or severe form in children and adolescents aged 6 to 17 years inclusive - with ineffectiveness, intolerance or contraindications to standard therapy, including corticosteroids and/or immunosuppressants.
Ulcerative colitis in adults when standard therapy is ineffective.
Moderate or severe ulcerative colitis in children and adolescents aged 6 to 17 years - with insufficient effectiveness of standard therapy using corticosteroids, 6-mercaptopurine or azathioprine, or in the presence of intolerance or contraindications to standard therapy.
Ankylosing spondylitis.
Psoriatic arthritis.
Psoriasis.
- Trade name:Remicade
- Chemical name:Infliximab
- Dosage:100 mg
- Quantity:1
- Dosage form:Vial
